Send to

Choose Destination
See comment in PubMed Commons below

Discovery of ML370, an inhibitor of Vibrio cholerae Quorum Sensing Acting via the LuxO response regulator.


Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2013 Apr 12 [updated 2014 Sep 18].

Author information

The Broad Institute Probe Development Center, Cambridge, MA
University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, KS
Princeton University, Princeton, NJ
Tufts University, Sackler School of Graduate Biomedical Sciences, Boston, MA
Department of Medicinal Chemistry, University of Kansas, Lawrence, KS
Chemical Biology Program, Broad Institute, Harvard University
Department of Chemistry & Chemical Biology, Harvard University


Quorum sensing (QS) is a process of bacterial cell-to-cell communication that relies upon recognition of extracellular signaling molecules called autoinducers. QS allows bacteria to synchronize their behavior in response to changes in the population density and species composition of the proximal bacterial community. Known behaviors regulated by QS include bioluminescence, sporulation, virulence factor production, and biofilm formation. We carried out a high throughput screen (HTS) to identify small molecules that modulate QS in a modified V. cholerae strain carrying a luciferase operon; activation of the quorum pathway is accompanied by light production. 352,083 compounds from the NIH-MLPCN compound library were evaluated. Potential QS modulators were characterized via additional bacterial epistatic assays to elucidate the mode of action. We report the discovery and medicinal chemistry development of a substituted pyrazoloquinoline (ML370) shown to be an inhibitor of Vibrio cholerae LuxO, a response regulator and intracellular kinase. The probe acts directly on LuxO by inhibiting the ATPase activity. ML370 should greatly expand the general understanding of how QS response regulators relay information from upstream signals that lead to modified gene expression. In addition ML370 and compound analogues could lead to the development of antibacterial drugs designed to interfere with QS that could have enormous ramifications for improving human health.

PubMed Commons home

PubMed Commons

How to join PubMed Commons
    Support Center